lunes, 12 de septiembre de 2016


Boletín semanal de ofertas de empleo publico

Institución:ProCURE, ICO-IDIBELL
Call for candidates selection


The Catalan Institute of Oncology (ICO, Barcelona) is a public center working exclusively in the field of cancer. Its approach to the disease is comprehensive, combining, all in one organization, prevention, care, specialized training and research. At present the ICO has four centers that work jointly with four university hospitals. It has its own territorial model and it is a multi-centric organization working in a coordinated way with 18 hospitals of the territory. Currently, ICO is an oncology referral center for 40% of the adult population of Catalonia. Research features as part of the primordial objective of the ICO, as stated in its founding Articles of Association.
ICO was founded in 1996 and it has become a center of reference in Catalonia, both in healthcare quality (satisfaction survey results and award for Best Clinical Practices from the National Health System, among others) and in research (top Spanish hospital-institute in terms of scientific quality). ICO has a strong track record of cooperation with other academic groups, with private companies and with public administration at international level, with partners in Europe and the Americas.
ICO carries out research in all areas of cancer, from understanding why it develops and how to prevent it, to finding early diagnosis strategies or new, more efficient treatments, as well as research related to caring for end-of-life patients. It also carries out research in nursing, psycho-oncology and social work.

Successful candidates will have the opportunity to initiate and conduct high-quality research within ProCURE (Program Against Cancer Therapeutic Resistance) at the ICO. Successful candidates will join a newly created translational research program focused on finding novel, advanced and personalized therapeutic strategies against cancer resistance. ProCURE involves strong clinical interactions and multidisciplinary approaches. The program offers a stimulating research atmosphere and an environment in which collaboration and exchange of ideas and techniques is actively encouraged with a strong commitment to translational research, which overall provides a lively and stimulating environment for young talents.
This ICO program conducts advanced and personalized research in cancer therapeutic resistance. ProCURE is constituted by eight research groups that have produced high-quality science in the following topics across major cancer types (breast, colorectal, lung, ovarian):
• Angiogenesis
• Cancer susceptibility and development
• Immunotherapy and oncolytic virus
• Metabolic stemness
• Patient-derived xenografts
• Stroma-tumor interaction
• Bioinformatics and Systems Biology

The aim of this call is the pre-selection carried out by ProCURE-ICO of excellent students with potential to win a Predoctoral FI AGAUR Fellowship:


Candidates can be of any nationality but should have prepared certification of her/his average academic score (calculation is detailed in the Call).
Academic degree:
- Not hold a doctoral degree.
- Average academic score should be > 2.5.
- Applicants may have experimental or bioinformatic experience.
- Applicants may also have certified animal experimentation.
- Extremely supportive referee letters.
- Articulate and mature approach to a doctorate goals.
Language skills:
- The candidate is expected to communicate fluently in English.

To apply, please send a cover letter containing a statement of research interest and experience (pdf), a CV (pdf) and supportive referee letters to:

DEADLINE to receive applications: 17 SEPTEMBER 2016

Información complementaria de la oferta:
Review of applications will start immediately and will continue until suitable candidates are found.
ProCURE will review candidates that have presented the complete documentation and fulfill the indicated requirements and promising candidates will be shortlisted. An interview shall be conducted before final decision.

No hay comentarios:

Publicar un comentario